MYOCARDIAL PERFORATION BY ENDOCARDIAL LEAD OF IMPLANTABLE ANTIARRHYTHMIC ELECTRONIC DEVICES
https://doi.org/10.17802/2306-1278-2026-15-1-203-211
Abstract
Highlights
- The article contains current literature data on risk factors, diagnosis and treatment of myocardial perforation by endocardial lead during implantation of pacemakers and cardioverter-defibrillators.
Absract
The increasing number of implantations of antiarrhythmic electronic implantable devices to an increase in the absolute number of complications. Cardiac perforation is a rare complication of pacemaker and cardioverter-defibrillator implantation, which can lead to death. Currently, there is no unequivocal opinion on the management tactics for patients with endocardial lead perforation. In this review, we summarize the current information on the main methods of diagnosis and treatment of myocardial perforation. Also, special attention is paid to the main factors contributing to the occurrence of this complication.
About the Authors
Aleksandr А. Sarychev
Federal State Public Healthcare Institution “Main Military Clinical Hospital of the National Guard of the Russian Federation;
Kazan State Medical Academy – Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Doctor of X-ray Endovascular Diagnostics and Treatment, Federal State Public Healthcare Institution “Main Military Clinical Hospital of the National Guard of the Russian Federation”, Balashikha, Russian Federation; Postgraduate student of the of the Department of Cardiology, X-ray Endovascular and Cardiovascular Surgery of the Surgical Faculty of the Kazan State Medical Academy – Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation, Kazan, Russian Federation
Il'dar V., Abdulyanov
Kazan State Medical Academy – Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation;
State Autonomous Institution of Health “Interregional Clinical and Diagnostic Center” of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
PhD, Associate Professor, Head of the Department of Cardiology, X-ray Endovascular and Cardiovascular Surgery of the Surgical Faculty of the Kazan State Medical Academy – Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation, Kazan, Russian Federation
Marat R. Zaynetdinov
State Autonomous Institution of Health “Interregional Clinical and Diagnostic Center” of the Ministry of Healthcare of the Russian Federation;
Federal State Budgetary Educational Institution of Higher Education “Kazan Medical University” of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Assistant of the Department of Cardiovascular and Endovascular Surgery of the Federal State Budgetary Educational Institution of Higher Education “Kazan Medical University” of the Ministry of Healthcare of the Russian Federation, Kazan, Russian Federation; Cardiovascular Surgeon of the Department of Cardiac Surgery No. 2 of the State Autonomous Institution of Health Interregional clinical diagnostic center”, Kazan, Russian Federation
References
1. Bokeriya L.A., Milievskaya E.B., Pryanishnikov V.V., Yurlov I.A., Kudzoeva Z.F. Cardiovascular Surgery – 2021. Diseases and congenital anomalies of the circulatory system. Moscow: NMICSSKH im. A.N. Bakuleva MZ RF; 2022. (In Russian)
2. Lin Y.S., Chen T.H., Hung S.P., Chen D.Y., Mao C.T., Tsai M.L., Chang S.T., Wang C.C., Wen M.S., Chen M.C. Impact of Pacemaker Lead Characteristics on Pacemaker Related Infection and Heart Perforation: A Nationwide Population-Based Cohort Study. PLoS One. 2015;10(6): e0128320. doi: 10.1371/journal.pone.0128320.
3. Kumar P., Skrabal J., Frasure S.E., Pourmand A. Pacemaker lead related myocardial perforation. Am J Emerg Med. 2022;53:281.e1-281.e3. doi: 10.1016/j.ajem.2021.08.081
4. Clémenty N., Fernandes J., Carion P.L., de Léotoing L., Lamarsalle L., Wilquin-Bequet F., Wolff C., Verhees K.J.P., Nicolle E., Deharo J.C. Pacemaker complications and costs: a nationwide economic study. J Med Econ. 2019;22(11):1171-1178. doi: 10.1080/13696998.2019.1652186.
5. Steinwender C., Lercher P., Schukro C., Blessberger H., Prenner G., Andreas M., Kraus J., Ammer M., Stühlinger M. State of the art: leadless ventricular pacing : A national expert consensus of the Austrian Society of Cardiology. J Interv Card Electrophysiol. 2020;57(1):27-37. doi: 10.1007/s10840-019-00680-2.
6. Hsu J.C., Varosy P.D., Bao H., Dewland T.A., Curtis J.P., Marcus G.M. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry. Circ Cardiovasc Qual Outcomes. 2013;6(5):582-90. doi: 10.1161/CIRCOUTCOMES.113.000299.
7. Demo H., Megaly M. Late perforation of a passively fixated pacemaker lead through the right ventricle. A report and review of literature. J Cardiol Cases. 2017;16(5):148-150. doi: 10.1016/j.jccase.2017.07.002.
8. Migliore F., Zorzi A., Bertaglia E., Leoni L., Siciliano M., De Lazzari M., Ignatiuk B., Veronese M., Verlato R., Tarantini G., Iliceto S., Corrado D. Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol. 2014;37(12):1602-9. doi: 10.1111/pace.12472.
9. Saprankov V.L., Bendov D.V., Ibragimov A.N., Gordeev M.L. Surgical management of delayed right heart perforation following antiarrhythmic device implantation. Russian Journal of Cardiology and Cardiovascular Surgery. 2021;14(4):325‑332. (In Russ.)
10. Waddingham P.H., Elliott J., Bates A., Bilham J., Muthumala A., Honarbakhsh S., Ullah W., Hunter R.J., Lambiase P.D., Lane R.E., Chow A.W.C. Iatrogenic cardiac perforation due to pacemaker and defibrillator leads: a contemporary multicentre experience. Europace. 2022 22;24(11):1824-1833. doi: 10.1093/europace/euac105.
11. Ghani A., Delnoy P.P., Ramdat Misier A.R., Smit J.J., Adiyaman A., Ottervanger J.P., Elvan A. Incidence of lead dislodgement, malfunction and perforation during the first year following device implantation. Neth Heart J. 2014;22(6):286-91. doi: 10.1007/s12471-014-0556-6.
12. Kirkfeldt R.E., Johansen J.B., Nohr E.A., Jorgensen O.D., Nielsen J.C. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186-94. doi: 10.1093/eurheartj/eht511.
13. Rajkumar C.A., Claridge S., Jackson T., Behar J., Johnson J., Sohal M., Amraoui S., Nair A., Preston R., Gill J., Rajani R., Rinaldi C.A. Diagnosis and management of iatrogenic cardiac perforation caused by pacemaker and defibrillator leads. Europace. 2017;19(6):1031-1037. doi: 10.1093/europace/euw074.
14. Vamos M., Erath J.W., Benz A.P., Bari Z., Duray G.Z., Hohnloser S.H. Incidence of Cardiac Perforation With Conventional and With Leadless Pacemaker Systems: A Systematic Review and Meta-Analysis. J Cardiovasc Electrophysiol. 2017;28(3):336-346. doi: 10.1111/jce.13140.
15. Zhou X., Ze F., Li D., Wang L., Guo J., Li X. Outcomes of transvenous lead extraction in patients with lead perforation: A single-center experience. Clin Cardiol. 2020;43(4):386-393. doi: 10.1002/clc.23327.
16. Rav Acha M., Rafael A., Keaney J.J., Elitzur Y., Danon A., Shauer A., Taha L., Shechter Y., Bogot N.R., Luria D., Ilan M., Singh S.M., Mela T., Weisz G., Glikson M., Medina A. The management of cardiac implantable electronic device lead perforations: a multicentre study. Europace. 2019;21(6):937-943. doi: 10.1093/europace/euz120.
17. Hirschl D.A., Jain V.R., Spindola-Franco H., Gross J.N., Haramati L.B. Prevalence and characterization of asymptomatic pacemaker and ICD lead perforation on CT. Pacing Clin Electrophysiol. 2007;30(1):28-32. doi: 10.1111/j.1540-8159.2007.00575.x
18. Verevetinov A.N., Tarasyuk E.S., Dorovskih I.E., Vakhnenko J.V., Nikitin V.N., Urazova G.E., Brueva O.N., Basanova I.V., Shkarban S.V. Clinical case of asymptomatic perforation of right ventricle during permanent pacemaker implantation. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2019;23(4):91-97. doi:10.21688/1681-3472-2019-4-91-97. (In Russian)
19. Mahapatra S., Bybee K.A., Bunch T.J., Espinosa R.E., Sinak L.J., McGoon M.D., Hayes D.L. Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm. 2005;2(9):907-11. doi: 10.1016/j.hrthm.2005.06.011.
20. Cano Ó., Andrés A., Alonso P., Osca J., Sancho-Tello M.J., Olagüe J., Martínez-Dolz L. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads. Europace. 2017;19(1):96-102. doi: 10.1093/europace/euv410.
21. Akbarzadeh M.A., Mollazadeh R., Sefidbakht S., Shahrzad S., Bahrololoumi Bafruee N. Identification and management of right ventricular perforation using pacemaker and cardioverter-defibrillator leads: A case series and mini review. J Arrhythm. 2017;33(1):1-5. doi: 10.1016/j.joa.2016.05.005.
22. Jessel P.M., Yadava M., Nazer B., Dewland T.A., Miller J., Stecker E.C., Bhamidipati C.M., Song H.K., Henrikson C.A. Transvenous management of cardiac implantable electronic device late lead perforation. J Cardiovasc Electrophysiol. 2020;31(2):521-528. doi: 10.1111/jce.14331.
23. Zhuang L., Mao Y., Wu L., Niu W., Chen K. Effects of right ventricular septum or His-bundle pacing versus right ventricular apical pacing on cardiac function: A systematic review and meta-analysis of randomized controlled trials. J Int Med Res. 2018;46(9):3848-3860. doi: 10.1177/0300060518781415.
24. Glikson M., Nielsen J.C., Kronborg M.B., Michowitz Y., Auricchio A., Barbash I.M., Barrabés J.A., Boriani G., Braunschweig F., Brignole M., Burri H., Coats A.J.S., Deharo J.C., Delgado V., Diller G.P., Israel C.W., Keren A., Knops R.E., Kotecha D., Leclercq C., Merkely B., Starck C., Thylén I., Tolosana J.M. Corrigendum to: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC): With the special contribution of the European Heart Rhythm Association (EHRA). 2022;24(1): :699. doi: 10.1093/europace/euac023.
25. Burri H., Starck C., Auricchio A., Biffi M., Burri M., D'Avila A., Deharo J.C., Glikson M., Israel C., Lau C.P., Leclercq C., Love C.J., Nielsen J.C., Vernooy K.; Reviewers:; Dagres N., Boveda S., Butter C., Marijon E., Braunschweig F., Mairesse G.H., Gleva M., Defaye P., Zanon F., Lopez-Cabanillas N., Guerra J.M., Vassilikos V.P., Martins Oliveira M. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS). Europace. 2021;23(7):983-1008. doi: 10.1093/europace/euaa367.
26. Celikyurt U., Acar B., Yavuz S., Agacdiken A., Vural A.. Predictors of the right ventricular perforation caused by active-fixation pacing and defibrillator leads: A single-centre experience. J Cardiovasc Electrophysiol. 2024;35(3):399-405. doi: 10.1111/jce.16181.
27. Elbatran A.I., Akhtar Z., Bajpai A., Leung L.W..M, Li A., Pearse S., Zuberi Z., Kaba R., Saba M.M., Norman M., Grimster A., Gallagher M.M., Sohal M. Percutaneous management of lead-related cardiac perforation with limited use of computed tomography and cardiac surgery. Pacing Clin Electrophysiol. 2021;44(4):614-624. doi: 10.1111/pace.14204.
28. Issa Z.F., Issa T.Z. Feasibility and Safety of Percutaneous Lead Revision for Subacute and Delayed Cardiac Device Lead Perforation. JACC Clin Electrophysiol. 2021;7(1):26-35. doi: 10.1016/j.jacep.2020.07.024.
29. Döring M., Müssigbrodt A., Ebert M., Bode K., Lucas J., Dagres N., Hindricks G., Richter S. Transvenous revision of leads with cardiac perforation following device implantation-Safety, outcome, and complications. Pacing Clin Electrophysiol. 2020;43(11):1325-1332. doi: 10.1111/pace.14056.
30. Zhang X., Zheng C., Wang P., Wang D., Huang B., Li G., Hu H., Yang Z., Duan X., Zheng S., Liu P., Wang J., Shen J. Assessment of Cardiac Lead Perforation: Comparison Among Chest Radiography, Transthoracic Echocardiography and Electrocardiography-gated Contrast-enhanced Cardiac CT. Eur Radiol. 2019;29(2):963-974. doi: 10.1007/s00330-018-5633-6.
31. Bhatia P., Chiou T., Svennberg E., Khoche S., Jacobs K., Pollema T., Pretorius V., Birgersdotter-Green U. Clinical significance of incidentally detected lead perforations by computed tomography. Pacing Clin Electrophysiol. 2021;44(5):936-942. doi: 10.1111/pace.14229.
32. Archontakis S., Sideris K., Aggeli K., Gatzoulis K., Demosthenous M., Tolios P., Lozos V., Koumallos N., Limperiadis D., Tousoulis D., Kallikazaros I., Sideris S. Percutaneous lead extraction and repositioning: An effective and safe therapeutic strategy for early ventricular lead perforation with dislocation both inside and outside the pericardial sac following a cardiac device implantation. J Cardiovasc Electrophysiol. 2019;30(3):299-307. doi: 10.1111/jce.13804.
33. Fiorillo G., Ghazihosseini S., Agizza S., Lanza F., Piccirillo S., Gargiulo G., Gargiulo P., Battista Pinna G., Pilato E., De Rosa C., Morisco C., Esposito G. Management of iatrogenic atrial perforation caused by pacemaker electrodes: a case report. J Med Case Rep. 2024;18(1):524. doi: 10.1186/s13256-024-04884-7.
34. Huang Y.Y., Chen P.Y., Lin Y.N., Lo C.. Uncommon Cardiac Perforation and Lead Displacement After Pacemaker Implantation: A Case Study and Diagnostic Insights. Am J Case Rep. 2024;25:e945008. doi: 10.12659/AJCR.945008.
35. Oda T., Kono T., Akaiwa K., Takahara Y., Yasuoka C., Nakamura K. Surgical Repair of Subacute Right Ventricular Perforation after Pacemaker Implantation. Case Rep Cardiol. 2017;2017:3242891. doi: 10.1155/2017/3242891.
36. Noguchi M., Nakai T., Kawano Y., Shibayama K., Obunai K., Tabata M., Watanabe H. Delayed right ventricular defibrillation lead perforation presenting as cardiac tamponade and treated surgically. Clin Case Rep. 2017 2;5(4):458-462. doi: 10.1002/ccr3.865.
37. Hamada Y., Sakaki M., Watanabe Y., Hata S., Kimura K., Sakagoshi N. Delayed Right Ventricular Pacemaker Lead Perforation 9 Years After Implantation. Am J Case Rep. 2023;24:e940291. doi: 10.12659/AJCR.940291.
38. Björkenheim A., Kalm T., Lidén M., Vidlund M. Right ventricular lead perforation with iatrogenic injury to an intercostal artery causing haemothorax after pacemaker implant. BMJ Case Rep. 2024;17(2):e258314. doi: 10.1136/bcr-2023-258314.
39. Van Gelder B.M., Verberkmoes N., Nathoe R., Bracke F.A. Late asymptomatic atrial lead perforation, a fortuitous finding during lead extraction using thoracoscopic surveillance: a case report and review of the literature. Europace. 2016;18(12):1773-1778. doi: 10.1093/europace/euw054.
40. Ayvazyan S.A., Gamzaev A.B., Palagina A.A., Gorshenin K.G., Buslaeva S.I., Seregin A.A., Konovalov N.S., Sapelnikov O.V. The Use of Transvenous Lead Extraction of Non-Infected Leads to Prevent Long-Term Lead-Related Complications. Sovrem Tekhnologii Med. 2021;13(1):66-69. doi: 10.17691/stm2021.13.1.08.
41. Maruya Y., Yamaura T., Mine H., Suzuki H. Successful pericardial repair and coverage for late pacemaker lead-related atrial perforation and pneumothorax: a case report. Gen Thorac Cardiovasc Surg Cases. 2023;2(1):102. doi: 10.1186/s44215-023-00117-3.
42.
Review
For citations:
Sarychev A.А., Abdulyanov I.V., Zaynetdinov M.R. MYOCARDIAL PERFORATION BY ENDOCARDIAL LEAD OF IMPLANTABLE ANTIARRHYTHMIC ELECTRONIC DEVICES. Complex Issues of Cardiovascular Diseases. 2026;15(1):203-211. (In Russ.) https://doi.org/10.17802/2306-1278-2026-15-1-203-211
Views:
25
JATS XML
